Molecular Imaging

Whether your prospective compound or novel radiotracer is in the early or late stage of trial development, CoreLab Partners' Molecular Imaging services can be leveraged to successfully gather, analyse and deliver crucial functional imaging data.

For early phase trials, we work with you to provide high-quality imaging efficacy data that empowers you to expedite critical go/no go decisions. Your team will be able to identify ineffective compounds earlier, saving valuable time and resources while allowing only your most promising compounds to advance in your drug development portfolio.

For late phase trials we provide functional imaging data which can be used as an exploratory endpoint or be integrated with the anatomic imaging data. This can be utilised for internal decision making and/or prepared for agency submission.

For more information please click here.